Last reviewed · How we verify

Jitongning tablets — Competitive Intelligence Brief

Jitongning tablets (Jitongning tablets) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Pain Management / Traditional Chinese Medicine.

phase 3 Pain Management / Traditional Chinese Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Jitongning tablets (Jitongning tablets) — Tasly Pharmaceutical Group Co., Ltd. Jitongning tablets work by improving blood circulation and reducing pain through traditional Chinese medicine principles, likely by promoting qi and blood flow.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Jitongning tablets TARGET Jitongning tablets Tasly Pharmaceutical Group Co., Ltd phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Jitongning tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/jitongning-tablets. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: